Vanguard Group »

Diamedica Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.0M 1.0M 2.95
2024-03-31 $2.8M 1.0M 2.77
2023-12-31 $2.3M 802k 2.84
2023-09-30 $2.0M 789k 2.58
2023-06-30 $3.4M 783k 4.32
2023-03-31 $1.2M 783k 1.53
2022-12-31 $1.2M 783k 1.58
2022-06-30 $1.6M 783k 2.02
2022-03-31 $2.0M 783k 2.50
2021-09-30 $3.2M 788k 4.01
2021-06-30 $3.4M 786k 4.35
2021-03-31 $7.8M 846k 9.20
2020-12-31 $8.0M 780k 10.22
2020-09-30 $1.4M 342k 4.24
2020-06-30 $1.7M 242k 6.93
2020-03-31 $677k 242k 2.80
2019-12-31 $393k 81k 4.85
2019-09-30 $166k 81k 2.05